The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: Detection of mutated TMPRSS2 form in a case of aggressive disease

International Journal of Cancer

Volumn 94, Issue 5, 2001, Pages 705-710

  Vaarala, Markku H ^a   Porvari, Katja ^a   Kyllönen, Atte ^a   Lukkarinen, Olavi ^a   Vihko, Pirkko ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

In situ hybridization; Mutation analysis; Serine protease

Indexed keywords

DNA; MESSENGER RNA; PROTEIN TMPRSS 2; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; DNA DETERMINATION; EXON; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; ORCHIECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE HYPERTROPHY; TUMOR DIFFERENTIATION;

HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES;

EID: 0035545817     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1526     Document Type: Article

References (22)

1. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q223
2. Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues
3. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2
4. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia
5. Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression
6. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
7. Chromosomal clues to the development of prostate tumors
8. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model
9. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression
10. Molecular cloning of the human kallikrein 15 gene (KLK15): Upregulation in prostate cancer
11. Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues
12. TNM classification of urological tumours in 1988
13. Loss of heterozygosity at 16q241-q242 is significantly associated with metastatic and aggressive behavior of prostate cancer
14. Sample preparation from paraffin-embedded tissues
15. Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts
16. Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization
17. Convenient single-step, one tube purification of PCR products for direct sequencing
18. Quantitation of erbB-2 gene copy number in breast cancer by an improved polymerase chain reaction (PCR) technique, competitively differential PCR
19. Antiangiogenic activity of prostate-specific antigen
20. The role for NES1 serine protease as a novel tumor suppressor
21. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues
22. Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: Epitheliasin